Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers

PURPOSE: The objective of this study was to estimate the risk of contralateral breast cancer in BRCA1 and BRCA2 carriers; and measure the extent to which host, family history, and cancer treatment-related factors modify the risk. PATIENTS AND METHODS: Patients were 810 women, with stage I or II brea...

Descripción completa

Detalles Bibliográficos
Autores principales: Metcalfe, K, Gershman, S, Lynch, H T, Ghadirian, P, Tung, N, Kim-Sing, C, Olopade, O I, Domchek, S, McLennan, J, Eisen, A, Foulkes, W D, Rosen, B, Sun, P, Narod, S A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101934/
https://www.ncbi.nlm.nih.gov/pubmed/21487411
http://dx.doi.org/10.1038/bjc.2011.120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101934/
https://www.ncbi.nlm.nih.gov/pubmed/21487411
http://dx.doi.org/10.1038/bjc.2011.120

Ejemplares similares